Literature DB >> 8133509

Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases.

Y P Goldberg1, S E Andrew, J Theilmann, B Kremer, F Squitieri, H Telenius, J D Brown, M R Hayden.   

Abstract

Huntington's disease (HD) is associated with expansion of a CAG repeat in a new gene. We have recently defined a premutation in a paternal allele of 30 to 38 CAG repeats in the HD gene which is greater than that seen in the general population (< 30 repeats) but below the range seen in patients with HD (> 38). These intermediate alleles are unstable during transmission through the germline and in sporadic cases expand to the full mutation associated with the clinical phenotype of HD. Here we have analysed three new mutation families where, in each, the proband and at least one sib have CAG sizes in the HD range. In one of these families, two sibs with expanded CAG repeats are both clinically affected with HD, thus presenting a pseudorecessive pattern of inheritance. In all three families the parental intermediate allele has expanded in more than one offspring, thus showing a previously unrecognised risk of inheriting HD to sibs of sporadic cases of HD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133509      PMCID: PMC1016629          DOI: 10.1136/jmg.30.12.987

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Parental age in acondroplasia and mongolism.

Authors:  L S PENROSE
Journal:  Am J Hum Genet       Date:  1957-09       Impact factor: 11.025

2.  Parental age and mutation.

Authors:  L S PENROSE
Journal:  Lancet       Date:  1955-08-13       Impact factor: 79.321

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Mutation in Huntington's chorea.

Authors:  D Stevens; M Parsonage
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-04       Impact factor: 10.154

5.  Parental age effects on the occurrence of new mutations for the Marfan syndrome.

Authors:  J L Murdoch; B A Walker; V A McKusick
Journal:  Ann Hum Genet       Date:  1972-03       Impact factor: 1.670

6.  Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects.

Authors:  Y P Goldberg; B Kremer; S E Andrew; J Theilmann; R K Graham; F Squitieri; H Telenius; S Adam; A Sajoo; E Starr
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

7.  Positron emission tomography in the early diagnosis of Huntington's disease.

Authors:  M R Hayden; W R Martin; A J Stoessl; C Clark; S Hollenberg; M J Adam; W Ammann; R Harrop; J Rogers; T Ruth
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

  7 in total
  9 in total

Review 1.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 2.  Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.

Authors:  H D Rosas; A S Feigin; Steven M Hersch
Journal:  NeuroRx       Date:  2004-04

Review 3.  Omental transplantation for neurodegenerative diseases.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

4.  Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysis.

Authors:  A Sánchez; S Castellví-Bel; M Milà; D Genis; M Calopa; D Jiménez; X Estivill
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

5.  Early onset Huntington disease: a neuronal degeneration syndrome.

Authors:  Sara Seneca; Domique Fagnart; Kathelijn Keymolen; Willy Lissens; Daniele Hasaerts; Sara Debulpaep; Brigitte Desprechins; Inge Liebaers; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

Review 6.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

7.  Proceed with care: direct predictive testing for Huntington disease.

Authors:  C M Benjamin; S Adam; S Wiggins; J L Theilmann; T T Copley; M Bloch; F Squitieri; W McKellin; S Cox; S A Brown
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

8.  Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications.

Authors:  D Brocklebank; J Gayán; J M Andresen; S A Roberts; A B Young; S R Snodgrass; J B Penney; M A Ramos-Arroyo; J J Cha; H D Rosas; S M Hersch; A Feigin; S S Cherny; N S Wexler; D E Housman; L R Cardon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

9.  Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration.

Authors:  Eng-Tat Ang; Yee-Kit Tai; Shun-Qiang Lo; Raymond Seet; Tuck-Wah Soong
Journal:  Front Aging Neurosci       Date:  2010-07-21       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.